Morgan Stanley maintains Allegion at Equal-Weight, raises price target to $181 from $170

What happened

Morgan Stanley kept its Equal-Weight rating on Allegion and raised its price target to $181 from $170, a 6.5% increase. The new target implies a 5.6% downside from the November 2 close of $191.73.

Confirmed

Global impact / market context

A higher target means Morgan Stanley sees more worth in Allegion, yet Equal-Weight means it expects the share price to roughly track the broader market rather than beat it. The target still sits below the last close, so the analyst sees limited upside.

Analyst inference

Other recent notes show targets from $183 to $206, with ratings ranging from Neutral to Outperform and Buy. That spread means analysts disagree on how much Allegion's earnings can grow, so investors weigh Morgan Stanley's cautious view against more optimistic peers.

Analyst inference

What to watch

1. Compare Morgan Stanley's $181 target with targets of $183 to $206 from other recent notes, since a wider gap signals growing disagreement about Allegion's prospects. Confirmed
2. Watch whether Allegion's next earnings report shows revenue growth or cost pressure strong enough to justify a higher target or a rating change from Equal-Weight. Proposed
3. Track the share price against the $191.73 close, because a move toward $181 would show investors accepting Morgan Stanley's more cautious valuation. Analyst inference

Evidence

• Original source link unavailable